List of Oxaydo drug patents

Oxaydo is owned by Zyla.

Oxaydo contains Oxycodone Hydrochloride.

Oxaydo has a total of 6 drug patents out of which 0 drug patents have expired.

Oxaydo was authorised for market use on 17 June, 2011.

Oxaydo is available in tablet;oral dosage forms.

The generics of Oxaydo are possible to be released after 16 March, 2025.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7981439 ZYLA Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof
Nov, 2023

(9 months from now)

US7510726 ZYLA Methods and compositions for deterring abuse of opioid containing dosage forms
Nov, 2023

(9 months from now)

US8409616 ZYLA Extended release opioid abuse deterrent compositions and methods of making same
Nov, 2023

(9 months from now)

US8637540 ZYLA Compositions for deterring abuse of opioid containing dosage forms
Nov, 2023

(9 months from now)

US9492443 ZYLA Abuse deterrent compositions and methods of making same
May, 2024

(1 year, 3 months from now)

US7201920 ZYLA Methods and compositions for deterring abuse of opioid containing dosage forms
Mar, 2025

(2 years from now)

Drugs and Companies using OXYCODONE HYDROCHLORIDE ingredient

Market Authorisation Date: 17 June, 2011

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of OXAYDO before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in